AI assistant
Sending…
Nykode Therapeutics ASA — Director's Dealing 2021
Sep 20, 2021
3695_dirs_2021-09-20_feca3ec7-7fae-4ee8-9782-5718a05f595e.html
Director's Dealing
Open in viewerOpens in your device viewer
Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party
Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party
Oppenheim AS has today sold 300,000 shares in Vaccibody AS to Axe Invest AS at NOK 71 per share. Following the transaction, Oppenheim AS holds no shares and Axe Invest AS holds 300,000 shares in Vaccibody AS.
Oppenheim AS and Axe Invest AS are 100% owned by Karoline Steiro, a closely associated person of Jan Haudemann-Andersen, member of the board of Vaccibody AS.
Please see further details in attached documents.
More from Nykode Therapeutics ASA
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 21
AGM Information
2026
Apr 21